Polomar Health Services, Inc. SEC filings PMHS
Polomar Health Services, Inc. has 150 filings in SEC EDGAR's recent list, going back to Sep 30, 2003. Its latest annual report, Form 10-K, was filed on May 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (restatement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Sep 17, 2025 | Jun 27, 2025 |
| 3 | Initial insider ownership | Oct 17, 2024 | Sep 30, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 11, 2024 | — |
| 3 | Initial insider ownership | Oct 7, 2024 | Oct 1, 2024 |
| 3 | Initial insider ownership | Jul 23, 2024 | Jul 18, 2024 |
| 3 | Initial insider ownership | Mar 28, 2024 | Mar 21, 2024 |
| 3 | Initial insider ownership | Jan 12, 2024 | Dec 29, 2023 |
| SC 13D | Ownership over 5% (active) | Jan 12, 2024 | — |
| 4 | Insider transaction | Sep 18, 2023 | Sep 12, 2023 |
| SC 13D | Ownership over 5% (active) | Aug 23, 2023 | — |
| 3 | Initial insider ownership | Aug 17, 2023 | Jul 31, 2023 |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PMHS (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Palm Harbor, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1265521
- Former names
- Trustfeed Corp. (until Oct 11, 2024); HEALTHMED SERVICES LTD (until Apr 5, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.